Home » Drug Information » FDA Approved Drugs » 1999

Rapamune (sirolimus) oral solution

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Wyeth

Approval Status:

Approved September 1999

Specific Treatments:

To prevent organ rejection in patients receiving renal transplants

Therapeutic Areas

Immunology

Find Related Trials for The Following Conditions

Transplant Rejection

General Information

An oral solution of sirolimus to act as a prophylaxis to prevent organ rejection in patients that are receiving liver transplants.

Mechanism of Action

Oral solution of sirolimus, 1 mg/ml.